CN1109508A - Full DNA sequence of recombinative glucokinase - Google Patents

Full DNA sequence of recombinative glucokinase Download PDF

Info

Publication number
CN1109508A
CN1109508A CN 95111222 CN95111222A CN1109508A CN 1109508 A CN1109508 A CN 1109508A CN 95111222 CN95111222 CN 95111222 CN 95111222 A CN95111222 A CN 95111222A CN 1109508 A CN1109508 A CN 1109508A
Authority
CN
China
Prior art keywords
lys
aaa
glu
val
gaa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95111222
Other languages
Chinese (zh)
Inventor
李伯刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shixin Medicine Tech Development Center Chengdu
Original Assignee
Shixin Medicine Tech Development Center Chengdu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shixin Medicine Tech Development Center Chengdu filed Critical Shixin Medicine Tech Development Center Chengdu
Priority to CN 95111222 priority Critical patent/CN1109508A/en
Publication of CN1109508A publication Critical patent/CN1109508A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention provides a recombinant staphylokinase DNA sequence, excluding signal peptidase, and number 33 basic group of the DNA is A, the number 275 basic group is T, the kinase DNA assembly expression vector to host bacteria, through transcription in the host bacteria, recombinant staphylokinase protein is translated to cure Myocardial Infarction, cerebral thrombosis and venous thrombosis disease such as deep venous thrombosis.

Description

Full DNA sequence of recombinative glucokinase
The present invention relates to a kind of recombinant DNA sequence, particularly relate to a kind of full DNA sequence of recombinant staphylokinase.
The external in recent years researchist as countries such as Belgium, Japan, Germany has done a large amount of research work at the preparation and the medical use this respect of recombinant staphylokinase, and enters the clinical experimental study stage.As " nucleic acids research " (Nucleic Acids Research) the 22nd phases 11 of nineteen eighty-three volume, be entitled as " Nucleotide sequence of the staphylokinase gene from Staphylococcus aureus " and reported a kind of nucleotide sequence of determining staphylokinase (Sak), its peptide sequence of inference has 163aa, signal peptide has 27aa, is positioned at NH2 and does not hold.
The object of the present invention is to provide a kind ofly not contain signal peptide, and the 33rd bit base of DNA is A that the 275th bit base is the full DNA sequence of the recombinant staphylokinase of T.
The full DNA sequence of recombinant staphylokinase of the present invention is:
TCA AGI TCA TTC GAC AAA GGA AAA
Ser Ser Ser Phe Asp Lys Gly Lys
TAT AAA AAA GGC GAT GAC GCG AGT
Tyr Lys Lys Gly Asp Asp Als Ser
TAT TTT GAA CCA ACA GGC CCG TAT
Tyt Phe Glu Pro Thr Gly Pro Tyr
TTG ATG GTA AAT GTG ACT GGA GTT
Leu Met Val Asn Val Thr Gly Val
GAT GGT AAA GGA AAT GAA TTG CTA
Asp Gly Lys Gly Asn Glu Leu Leu
TCC CCT CAT TAT GTC GAG TTT CCT
Ser Pro His Tyr Val Glu Phe Pro
ATT AAA CCT GGG ACT ACA CTT ACA
Ile Lys Pro Gly Thr Thr Leu Thr
AAA GAA AAA ATT GAA TAC TAT GTC
Lys Glu Lys Ile Glu Tyr Tyr Val
GAA TGG GCA TTA GAT GCG ACA GCA
Glu Trp Ala Leu Asp Ala Thr Ala
TAT AAA GAG TTT AGA GTA GTT GAA
Tyr Lys Glu Phe Arg Val Val Glu
TTA GAT CCA AGC GCA AAG ATC GAA
Leu Asp Pro Ser Ala Lys Ile Glu
GTC ACT TAT TTT GAT AAG AAT AAG
Val Thr Tyr Phe Asp Lys Asn Lys
AAA AAA GAA GAA ACG AAG TCT TTC
Lys Lys Glu Glu Thr Lys Ser Phe
CCT ATA ACA GAA AAA GGT TTT GTT
Pro Ile Thr Glu Lys Gly Phe Val
GTC CCA GAT TTA TCA GAG CAT ATT
Val Pro Asp Leu Ser Glu His Ile
AAA AAC CCT GGA TTC AAC TTA ATT
Lys Asn Pro Gly Phe Asn Leu Ile
ACA AAG GTT GTT ATA GAA AAG AAA
Thr Lys Val Val Ile Glu Lys Lys
The full DNA sequence assembling expression vector of recombinant staphylokinase of the present invention is transformed into the host bacterium, by transcribing, translates into recombinant staphylokinase protein in the host bacterium.Can be used for treating thrombotic diseases such as myocardial infarction, cerebral thrombosis, degree of depth phlebothrombosis.
Describe the present invention's preparation and mensuration in detail below in conjunction with embodiment.The preparation of the full DNA sequence of recombinant staphylokinase of the present invention is:
1) screening of gold-coloured staphylococci: at first streptococcus aureus (S.aurens) is inserted the LB substratum of 50ml, cultivated 8 hours under 37 ℃ of temperature, rule on the flat board of LB-agar 1.5% 37 ℃ of following overnight incubation of temperature then.Picking list bacterium colony increases in the LB of 5ml nutrient solution, 37 ℃ of following overnight incubation of temperature, centrifugal collection supernatant liquor.Measure the activity of staphylokinase (Sak) in the supernatant liquor with the chromophoric substrate method, obtain the bacterial classification of two the highest single bacterium colonies of Sak activity altogether, be numbered S-1 respectively, S-29 as the streptococcus aureus that will screen (S.aurens), wherein the fibrinolytic of S-29 is higher, so be alternative.
2) has the extraction of the streptococcus aureus S-29 chromosomal DNA of fibrinolytic: streptococcus aureus S-29 is seeded in the LB substratum of 250ml with the ratio of 1:100, in 37 ℃ of temperature, constant-temperature shaking culture is 18 hours under the condition that rotating speed is 250 rev/mins, add each 250 μ g of DNAaseI and RNAase again, room temperature reaction 30 minutes, add solid 1.46gNacl then, waited to dissolve rearmounted ice bath 1 hour, under 4 ℃ of temperature, 11000 rev/mins of conditions of rotating speed centrifugal 10 minutes, collect supernatant liquor.In supernatant liquor, add 25g polyoxyethylene glycol 8000(PEG8000), ice bath 1 hour once more after waiting to dissolve.Under 4 ℃ of temperature, 11000 rev/mins of conditions of rotating speed centrifugal 10 minutes then, collecting precipitation.SM solution (Tris-Hcl of 5.8gNacl, 2gMgSO417H2O, 50ml concentration 1mmol/l, pH7.5,2% gelatin 5ml, adding distil water are to the 1000ml) dissolution precipitation that adds 4ml in precipitation gets crude extract.Add the equal-volume chloroform in crude extract, mixing under 4 ℃ of temperature, 3000 rev/mins of conditions of rotating speed centrifugal 15 minutes, is collected water.Centrifugal 2 hours again with 2500 rev/mins rotating speed, collecting precipitation.With the SM solution dissolution precipitation of 100ml, temperature is placed down for 4 ℃ and is spent the night.Adding Proteinase K (prote-inase k) to this Proteinase K final concentration then is 50 μ/μ g, add simultaneously 10% SDS to its final concentration be 0.5%, in the reaction hour down of 56 ℃ of temperature, be cooled to room temperature.Use phenol, phenol-chloroform, each extracting of chloroform respectively once.Add the sodium-acetate that 1/10 volumetric concentration is 3mol/l (PH7.0), the dehydrated alcohol that adds 2.5 times of volumes again precipitates.(concentration is that Tris-hcl and the concentration of 10mmol/l is the EDTA of 1mmol/l, and PH8.0) dissolution precipitation obtains phage DNA, and golden Portugal bacterium phage DNA collection of illustrative plates is preserved standby down in-20 ℃ as shown in Figure 1 to use TE solution at last.
3) amplification of recombinant staphylokinase gene: (S-phi-C DNA) is template with phage, by primer 1, primer 2, adopts PCR method amplification glucokinase gene, and the PCR reaction solution is:
Distilled water 33 μ l μ
10 * PCR damping fluid, 5 μ l
dNTP(2.5mmol/l) 4μl
Primer 1(100pmol) 1 μ l
Primer 2 (100pmol) 1 μ l
Phage S-Phi-CDNA(0.22 μ g/ μ l) 5 μ l
Mixing, 95 ℃ of following thermally denatures of temperature 5 minutes, ice bath immediately, adding 1 μ l concentration is the Taq polysaccharase of 2.5u/ml, the 50ml whiteruss.
Test kit PCR reaction conditions: each circulation is included in temperature and reacted 52 seconds down for 92 ℃; Reacted 60 seconds down for 55 ℃ in temperature; Reacted 70 seconds down for 72 ℃ in temperature; Circulate altogether 30 times.Under 72 ℃ of temperature, reacted again 15 minutes at last.Get 5 μ l electrophoresis detection, the dna segment about 400bp appears in electrophoresis detection (1% gel) PCR reaction product, and the PCR product collection of illustrative plates of SAK as shown in Figure 2.
The clone of glucokinase gene of the present invention and sequencing thereof are that above-mentioned dna segment is cut with restriction enzyme EcoR I and BamH1 enzyme respectively with carrier M13mp19, two segments after enzyme is cut connect with ligase enzyme T4DNA ligase again, the connector coated plate, choose positive colony, called after pDAGI, and carry out sequencing.(measure test kit available from Promega dna sequence analysis test kit, connect test kit and will show operation.Order-checking is undertaken by Ri Benjin swamp medical college).
Order-checking instrument: dna sequencing instrument (A.L.F.DNA SegnncerTM)
Sequential analysis:
Computer software A.L.F.Manager V2.5 Experinental
COnditions
Voltage 1500V
Electric current 38mA
Power 34W
Sample room was every 2 seconds
360 minutes time
40 ℃ of temperature
Probe power (laser intensity) 3mW
Clone's used carrier puc19 (ECoRI-Sakgene-BamH1-S
akgene)
The clone uses primer forward primer Puc18 primer-40
Reverse primer puc18 Reverse primer
Sequencing result as shown in Figure 3.

Claims (1)

1, a kind of full DNA sequence of recombinant staphylokinase, its sequence is:
TCA AGT TCA TTC GAC AAA GGA AAA
Ser Ser Ser Phe Asp Lys Gly Lys
TAT AAA AAA GGC GAT GAC GCG AGT
Tyr Lys Lys Gly Asp Asp Als Ser
TAT TTT GAA CCA ACA GGC CCG TAT
Tyt Phe Glu Pro Thr Gly Pro Tyr
TTG ATG GTA AAT GTG ACT GGA GTT
Leu Met Val Asn Val Thr Gly Val
GAT GGT AAA GGA AAT GAA TTG CTA
Asp Gly Lys Gly Asn Glu Leu Leu
TCC CCT CAT TAT GTC GAG TTT CCT
Ser Pro His Tyr Val Glu Phe Pro
ATT AAA CCT GGG ACT ACA CTT ACA
Ile Lys Pro Gly Thr Thr Leu Thr
AAA GAA AAA ATT GAA TAC TAT GTC
Lys Glu Lys Ile Glu Tyr Tyr Val
GAA TGG GCA TTA GAT GCG ACA GCA
Glu Trp Ala Leu Asp Ala Thr Ala
TAT AAA GAG TTT AGA GTA GTT GAA
Tyr Lys Glu Phe Arg Val Val Glu
TTA GAT CCA AGC GCA AAG ATC GAA
Leu Asp Pro Ser Ala Lys Ile Glu
GTC ACT TAT TTT GAT AAG AAT AAG
Val Thr Tyr Phe Asp Lys Asn Lys
AAA AAA GAA GAA ACG AAG TCT TTC
Lys Lys Glu Glu Thr Lys Ser Phe
CCT ATA ACA GAA AAA GGT TTT GTT
Pro Ile Thr Glu Lys Gly Phe Val
GTC CCA GAT TTA TCA GAG CAT ATT
Val Pro Asp Leu Ser Glu His Ile
AAA AAC CCT GGA TTC AAC TTA ATT
Lys Asn Pro Gly Phe Asn Leu ILe
ACA AAG GTT GTT ATA GAA AAG AAA
Thr Lys Val Val Ile Glu Lys Lys
CN 95111222 1995-01-23 1995-01-23 Full DNA sequence of recombinative glucokinase Pending CN1109508A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95111222 CN1109508A (en) 1995-01-23 1995-01-23 Full DNA sequence of recombinative glucokinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95111222 CN1109508A (en) 1995-01-23 1995-01-23 Full DNA sequence of recombinative glucokinase

Publications (1)

Publication Number Publication Date
CN1109508A true CN1109508A (en) 1995-10-04

Family

ID=5078532

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95111222 Pending CN1109508A (en) 1995-01-23 1995-01-23 Full DNA sequence of recombinative glucokinase

Country Status (1)

Country Link
CN (1) CN1109508A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004017A1 (en) * 1997-07-19 1999-01-28 Bai Hansan Recombinant staphylokinase and their high expression engineered strain
CN1064406C (en) * 1998-05-11 2001-04-11 中国人民解放军军事医学科学院微生物流行病研究所 Method for producing glucokinase by gene engrg. technique
WO2001055359A1 (en) * 2000-01-28 2001-08-02 Fudan University A novel recombinant staphylokinase derivant and its preparation method and application thereof
CN1108816C (en) * 2000-01-05 2003-05-21 复旦大学 Gluconokinase microemulsion and preparing process thereof
CN1110320C (en) * 2000-01-28 2003-06-04 复旦大学 Medicine preparation containing glucokinase and its preparation method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999004017A1 (en) * 1997-07-19 1999-01-28 Bai Hansan Recombinant staphylokinase and their high expression engineered strain
CN1059926C (en) * 1997-07-19 2000-12-27 张其玖 Glucokinase gene and its high expression engineering strain
CN1064406C (en) * 1998-05-11 2001-04-11 中国人民解放军军事医学科学院微生物流行病研究所 Method for producing glucokinase by gene engrg. technique
CN1108816C (en) * 2000-01-05 2003-05-21 复旦大学 Gluconokinase microemulsion and preparing process thereof
WO2001055359A1 (en) * 2000-01-28 2001-08-02 Fudan University A novel recombinant staphylokinase derivant and its preparation method and application thereof
CN1110320C (en) * 2000-01-28 2003-06-04 复旦大学 Medicine preparation containing glucokinase and its preparation method

Similar Documents

Publication Publication Date Title
CN1280422C (en) Asymmetrical PCR amplification method, dedicated primer and use thereof
Lefmann et al. Novel mass spectrometry-based tool for genotypic identification of mycobacteria
EP0245129B1 (en) Oligonucleotide probes and methods of detection by hybridization of nucleic acids from bacteria and other live organisms
JP4422019B2 (en) Microbe identification probe and identification method using the same
JPH04500315A (en) Universal Eubacterial Nucleic Acid Probe and Method
CN87108073A (en) Adopt hybridization assays HTLV I and II
CN115772518A (en) Primer composition for simultaneously detecting at least eight blood stream infection pathogens and application thereof
CN1109508A (en) Full DNA sequence of recombinative glucokinase
CN113817708B (en) Recombinant DNA polymerase, preparation method and application thereof
EP2462244B1 (en) Non-mass determined base compositions for nucleic acid detection
Revazishvili et al. Characterisation of Yersinia pestis isolates from natural foci of plague in the Republic of Georgia, and their relationship to Y. pestis isolates from other countries
CN1467294A (en) Multiplex pcr primer set for human glucokinase gene amplification
US20060099618A1 (en) Detection, identification and differentiation of Serratia species using the spacer region
CN108517357B (en) Kit for detecting sudden cardiac death-related SNP (single nucleotide polymorphism) on SCN5A gene related to sudden cardiac death and detection method thereof
Montoya et al. Application of microsatellite genotyping to the study of a restricted Leishmania infantum focus: different genotype compositions in isolates from dogs and sand flies
CN110628920A (en) Fluorescence labeling multiplex amplification kit for 35 STR loci of human Y chromosome and application thereof
WO2018130692A1 (en) Rapid antimicrobial susceptibility testing and phylogenetic identification
CN110257505B (en) Non-deletion α thalassemia point mutation rapid detection kit and detection method
CN115851921A (en) Primer probe combination product, kit and application of primer probe combination product and kit in nasopharyngeal carcinoma methylation detection
CN110184363B (en) Primer group and kit for detecting salmonella
Grothues et al. Separation of up to 1000 bases on a modified ALF DNA sequencer.
WO2019132582A1 (en) Method for analyzing str of human subject by using multiplex system, and analysis kit using same
KR101925974B1 (en) Composition for diagnosis of neurofibromatosis comprising long PCR primer set based on genomic DNA
Lareu et al. Sequence variation of a variable short tandem repeat at the D18S535 locus
KR20100012319A (en) Methods for classifying and identifying sepsis-causing microorganisms

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication